Evidence map›Paper›PMID 38405466›Full record

ArticleACS omega2024

Imran Ahmad, Anil Kumar Singh, Shayan Mohd, Sudheer Kumar Katari, Ravina Madhulitha Nalamolu, Abrar Ahmad, Othman A Baothman, Salman A Hosawi, Hisham Altayeb, Muhammad Shahid Nadeem and 1 more

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Imran AhmadDepartment of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh 226003, India.
Anil Kumar SinghEnvironmental Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhavan, 31, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh 226001, India.ORCID https://orcid.org/0000-0002-5721-6502
Shayan MohdDepartment of Bioengineering, Faculty of Engineering, Integral University, Dasauli, Kursi Road, Lucknow 226026, India.
Sudheer Kumar KatariDepartment of Biotechnology, Vignan's Foundation for Science, Technology & Research, Vadlamudi, Andhra Pradesh 522213, India.
Ravina Madhulitha NalamoluDepartment of Biotechnology, Vignan's Foundation for Science, Technology & Research, Vadlamudi, Andhra Pradesh 522213, India.
Abrar AhmadDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0001-9439-7712
Othman A BaothmanDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
Salman A HosawiDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
Hisham AltayebDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0002-2635-9383
Muhammad Shahid NadeemDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
Varish AhmadDepartment of Health Information Technology, Faculty of Applied Studies, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An assortment of environmental matrices includes arsenic (As) in its different oxidation states, which is often linked to concerns that pose a threat to public health worldwide. The current difficulty lies in addressing toxicological concerns and achieving sustained detoxification of As. Multiple conventional degradation methods are accessible; however, they are indeed labor-intensive, expensive, and reliant on prolonged laboratory evaluations. Molecular interaction and atomic level degradation mechanisms for enzyme-As exploration are, however, underexplored in those approaches. A feasible approach in this case for tackling this accompanying concern of As might be to cope with undertaking multivalent computational methodologies and tools. This work aimed to provide molecular-level insight into the enzyme-aided As degradation mechanism. AutoDock Vina, CABS-flex 2.0, and Desmond high-performance molecular dynamics simulation (MDS) were utilized in the current investigation to simulate multivalent molecular processes on two protein sets: arsenate reductase (ArsC) and laccase (LAC) corresponding arsenate (ART) and arsenite (AST), which served as model ligands to comprehend binding, conformational, and energy attributes. The structural configurations of both proteins exhibited variability in flexibility and structure framework within the range of 3.5-4.5 Å. The LAC-ART complex exhibited the lowest calculated binding affinity, measuring -5.82 ± 0.01 kcal/mol. Meanwhile, active site residues ILE-200 and HIS-206 were demonstrated to engage in H-bonding with the ART ligand. In contrast to ArsC, the ligand binding affinity of this bound complex was considerably greater. Additional validation of docked complexes was carried out by deploying Desmond MDS of 100 ns to capture protein and ligand conformation behavior. The system achieved stability during the 100 ns simulation run, as confirmed by the average P-L RMSD, which was ∼1 Å. As a preliminary test of the enzyme's ability to catalyze As species, corresponding computational insights might be advantageous for bridging gaps and regulatory consideration.

Identifiers

PMID38405466
PMCPMC10882604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.